Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |